New at #ATS2025:
Dupilumab (DUPIXENT) significantly reduced #asthma exacerbations/improved control in children with moderate-to-severe type 2 asthma, new data suggest, regardless of duration. This was a post-hoc analysis led by @wphipmd.
🔗View summary:
https://t.co/gq6ImXHSid
💬The fact that #dupilumab improves outcomes for children regardless of the duration of their #asthma underscores its well-established safety and efficacy, said Dr. Wanda Phipatanakul of @BostonChildrens.
@HealioPulm@wphipmd@atscommunity
https://t.co/lKiozAV4Ng
This supports prior observational studies suggesting that vit. D sufficiency mitigates detrimental effects of oxidative stress from outdoor pollutants and second-hand smoke on asthma+ lung function in childhood. @EFornoMD@wphipmd@YYHan_Epi@UPMCPhysicianEd@PittTweet@ATS_AII
📣 What is the most #rewarding part about being a #mentor?
For @wphipmd, she feels when her #mentee succeeds, everybody succeeds.
Read Phipatanakul's conversation with Healio's Women in Allergy below. ⬇️
https://t.co/lYqDTMZCVx
Asthma/sleep-disordered breathing overlap is highly prevalent among school-age children in low-income urban neighborhoods and is associated with poorer lung function and atopy, especially rhinitis. @AnnalsATS@SeyniGN@SusanRedline@wphipmd@garyadam67
https://t.co/gipkDdmyE9
Headed to @atscommunity in May and interested in learning about the mechanisms, physiology and management of immune mediated airway diseases such as asthma & COPD, with a focus on type 2 inflammation? We've got the course from you!
Details/registration: https://t.co/oknT1xIzm5
Ayobami Akenroye from Harvard Medical School, USA, presents their research article published in Allergy:
Nopsopon T, Barrett NA, Phipatanakul W, Laidlaw TM, Weiss ST, Akenroye A. Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy. 2024;
Read the article here: https://t.co/saFRIseQst
Watch videos of recent discoveries: https://t.co/WsHBrsUyhR and https://t.co/cHKAG7swDc
#Allergy_journal
https://t.co/2yZP4yfgEB
1.4.24 1150 AM ET CNN/ CNN International Anchor of State of the Race Kasie Hunt, @kasie w/ Politics Reporter at the Des Moines Register, Galen Bacharier @galenbacharier Topic: Iowa Excellent and Informative Segment (6 minutes)
Children with high IL-6 levels exposed to increasing levels of mouse allergen had lower FEV1/FVC than children with moderate or low levels, said Dr. Wanda Phipatanakul of @BostonChildrens. Also, @slovinskydesir of @LungAssociation comments. @wphipmd
https://t.co/E9bJ4O2fOF
High levels of IL-6 appear to increase susceptibility to the effects that classroom exposure to mouse allergen has on lung function, aid Dr. Wanda Phipatanakul of @BostonChildrens. Also, @slovinskydesir of @LungAssociation comments. @wphipmd#asthma
https://t.co/E9bJ4O2fOF
Food allergy in infancy, whether it resolves or not, is associated with lung function deficits and asthma at age 6 years. Study in @LancetChildAdol. @wphipmd#pulmtwitter#pulmonology
https://t.co/1l0nx8oxOW